Enteropathogenic E. coli non-LEE encoded effectors NleH1 and NleH2 attenuate NF-κB activationROYAN, Sandhya V; JONES, Rheinallt M; RHEE, Ki-Jong et al.Molecular microbiology (Print). 2010, Vol 78, Num 5, pp 1232-1245, issn 0950-382X, 14 p.Article

Lymphocyte transformation by Pim-2 is dependent on nuclear factor-κB activationHAMMERMAN, Peter S; FOX, Casey J; CINALLI, Ryan M et al.Cancer research (Baltimore). 2004, Vol 64, Num 22, pp 8341-8348, issn 0008-5472, 8 p.Article

Pulsatile Stimulation Determines Timing and Specificity of NF-KB-Dependent TranscriptionASHALL, Louise; HORTON, Caroline A; KELL, Douglas B et al.Science (Washington, D.C.). 2009, Vol 324, Num 5924, pp 242-246, issn 0036-8075, 5 p.Article

The LMP1 Promoter Can Be Transactivated Directly by NF-KBDEMETRIADES, Constantinos; MOSIALOS, George.Journal of virology. 2009, Vol 83, Num 10, pp 5269-5277, issn 0022-538X, 9 p.Article

Farnesoid X Receptor Antagonizes Nuclear Factor κB in Hepatic Inflammatory ResponseWANG, Yan-Dong; CHEN, Wei-Dong; MEIHUA WANG et al.Hepatology (Baltimore, Md.). 2008, Vol 48, Num 5, pp 1632-1643, issn 0270-9139, 12 p.Article

The Akt inhibitor deguelin, is an angiopreventive agent also acting on the NF-κB pathwayDELL'EVA, Raffaella; AMBROSINI, Claudia; MINGHELLI, Simona et al.Carcinogenesis (New York. Print). 2007, Vol 28, Num 2, pp 404-413, issn 0143-3334, 10 p.Article

Inhibition of Nuclear Factor-κB DNA Binding by Organoselenocyanates through Covalent Modification of the p50 SubunitCHEN, Kun-Ming; SPRATT, Thomas E; EL-BAYOUMY, Karam et al.Cancer research (Baltimore). 2007, Vol 67, Num 21, pp 10475-10483, issn 0008-5472, 9 p.Article

Resveratrol prevents interleukin release from isolated monocytesBERTELLI, A. A. E; MIGLIORI, M; GIOVANNINI, L et al.International journal of immunotherapy. 2002, Vol 18, Num 3-4, pp 83-86, issn 0255-9625, 4 p.Article

Nuclear Factor-κB, an Unappreciated Tumor SuppressorFEI CHEN; CASTRANOVA, Vince.Cancer research (Baltimore). 2007, Vol 67, Num 23, pp 11093-11098, issn 0008-5472, 6 p.Article

Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-κB activation and transformation in resistant JB6 cellsJING HU; NAKANO, Hiroyasu; SAKURAI, Hiroaki et al.Carcinogenesis (New York. Print). 2004, Vol 25, Num 10, pp 1991-2003, issn 0143-3334, 13 p.Article

Control of NF-κB Activity by ProteolysisBAUD, Veronique; DERUDDER, Emmanuel.Current Topics in Microbiology and Immunology. 2011, Vol 349, pp 97-114, issn 0070-217X, 18 p.Article

NF-κB and Innate ImmunityDEV, Anurupa; IYER, Shankar; RAZANI, Bahram et al.Current Topics in Microbiology and Immunology. 2011, Vol 349, pp 115-143, issn 0070-217X, 29 p.Article

NF-κB and Mucosal HomeostasisECKMANN, Lars; NEISH, Andrew S.Current Topics in Microbiology and Immunology. 2011, Vol 349, pp 145-158, issn 0070-217X, 14 p.Article

Disruption of NF-κB signalling by ancient microbial molecules: novel therapies of the future?FANG YAN; POLK, D. Brent.Gut. 2010, Vol 59, Num 4, pp 421-426, issn 0017-5749, 6 p.Article

Human Metapneumovirus Small Hydrophobic Protein Inhibits NF-κB Transcriptional ActivityXIAOYONG BAO; KOLLI, Deepthi; TIANSHUANG LIU et al.Journal of virology. 2008, Vol 82, Num 16, pp 8224-8229, issn 0022-538X, 6 p.Article

LMP1 transmembrane domain 1 and 2 (TM1-2) FWLY mediates intermolecular interactions with TM3-6 to activate NF-κBSONI, Vishal; YASUI, Teruhito; CAHIR-MCFARLAND, Ellen et al.Journal of virology. 2006, Vol 80, Num 21, pp 10787-10793, issn 0022-538X, 7 p.Article

Chemoresistance: Impact of nuclear factor (NF)-κB inhibition by small interfering RNAVEIBY, Ole Petter; READ, Margaret A.Clinical cancer research. 2004, Vol 10, Num 10, pp 3262-3264, issn 1078-0432, 3 p.Article

Nuclear factor (NF)-κB proteins: therapeutic targetsVERMA, I. M.Annals of the rheumatic diseases. 2004, Vol 63, pp ii57-ii61, issn 0003-4967, SUP2Article

Physical and functional interaction between the ID1 and p65 for activation of NF-κBXIAO PENG; YUNA WANG; KOLLI, Swapna et al.American journal of physiology. Cell physiology. 2012, Vol 72, Num 2, issn 0363-6143, C267-C277Article

Sef Is an Inhibitor of Proinflammatory Cytokine Signaling, Acting by Cytoplasmic Sequestration of NF-κBFUCHS, Yaron; BRUNWASSER, Michal; CARMI, Yaron et al.Developmental cell. 2012, Vol 23, Num 3, pp 611-623, issn 1534-5807, 13 p.Article

NF-κB in Renal InflammationBELEN SANZ, Ana; SANCHEZ-NINO, Maria Dolores; RAMOS, Adrian Mario et al.Journal of the American Society of Nephrology. 2010, Vol 21, Num 8, pp 1254-1262, issn 1046-6673, 9 p.Article

An Intronic Enhancer Driven by NF-κB Contributes to Transcriptional Regulation of Peptidylarginine Deiminase Type I Gene in Human KeratinocytesSHIBO YING; KOJIMA, Toshio; KAWADA, Akira et al.Journal of investigative dermatology. 2010, Vol 130, Num 11, pp 2543-2552, issn 0022-202X, 10 p.Article

A critical role of TAK1 in B-cell receptor―mediated nuclear factor κB activationSCHUMAN, James; YUHONG CHEN; PODD, Andrew et al.Blood. 2009, Vol 113, Num 19, pp 4566-4574, issn 0006-4971, 9 p.Article

Timed NF-κB Inhibition in Skin Reveals Dual Independent Effects on Development of HED/EDA and Chronic InflammationULVMAR, Maria H; SUR, Inderpreet; MEMET, Sylvie et al.Journal of investigative dermatology. 2009, Vol 129, Num 11, pp 2584-2593, issn 0022-202X, 10 p.Article

Voie alternative d'activation de NF-κB et cancer : Amis ou ennemis ? = The alternative NF-κB activation pathway and cancer : friend or foe?BAUD, Véronique; JACQUE, Emilie.MS. Médecine sciences. 2008, Vol 24, Num 12, pp 1083-1088, issn 0767-0974, 6 p.Article